24-months Study to Evaluate Safety and Efficacy of Peroneal Transcutaneous NeuroModulation in Subjects With Parkinson's Disease and Essential Tremor

NCT06570421 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease
Essential Tremor

Interventions

DEVICE: Peroneal electrical transcutaneous neuromodulation (peroneal eTNM®)

Sponsor

Stimvia s.r.o.